Qiu-Yan Chen Selected Research

toripalimab

11/2023	Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
1/2022	Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
1/2021	Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiu-Yan Chen Research Topics

Disease

134	Nasopharyngeal Carcinoma 12/2023 - 04/2004
38	Neoplasm Metastasis (Metastasis) 05/2023 - 06/2011
36	Neoplasms (Cancer) 11/2023 - 04/2004
4	Necrosis 11/2023 - 01/2019
4	Mucositis 01/2023 - 02/2010
3	Disease Progression 11/2023 - 11/2015
3	Neutropenia 01/2023 - 09/2013
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 02/2010
2	Leukopenia 01/2023 - 12/2018
2	Hearing Loss (Hearing Impairment) 01/2023 - 01/2020
2	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2018
2	Anemia 10/2021 - 01/2015
2	Bites and Stings (Sting) 07/2020 - 11/2019
2	Xerostomia 01/2020 - 01/2013
2	Stomatitis 10/2019 - 09/2013
2	Venous Thromboembolism 12/2018 - 01/2018
1	Radiation Injuries (Radiation Sickness) 11/2023
1	Infections 01/2023
1	Tertiary Lymphoid Structures 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 05/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Carcinoma (Carcinomatosis) 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Trismus (Lockjaw) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Dermatitis 01/2020
1	Pain (Aches) 10/2019
1	Lymphadenopathy 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018
1	Anorexia 01/2018

Drug/Important Bio-Agent (IBA)

38	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2013
22	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 02/2010
8	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 04/2004
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
6	Capecitabine (Xeloda)FDA Link 12/2023 - 04/2004
5	Docetaxel (Taxotere)FDA Link 12/2023 - 02/2010
5	Gemcitabine FDA Link 11/2023 - 01/2020
4	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 11/2022 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 07/2020 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 12/2007
3	toripalimabIBA 11/2023 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 12/2018
3	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2019
3	ChemokinesIBA 01/2023 - 12/2007
3	PlatinumIBA 01/2023 - 02/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021 - 08/2013
3	CytokinesIBA 07/2020 - 10/2012
3	Viral DNAIBA 01/2019 - 11/2015
3	Indicators and Reagents (Reagents)IBA 12/2015 - 06/2011
2	apatinibIBA 01/2023 - 01/2023
2	LigandsIBA 01/2023 - 01/2020
2	nedaplatinIBA 12/2021 - 01/2018
2	EnzymesIBA 10/2021 - 02/2016
2	Cetuximab (Erbitux)FDA Link 01/2019 - 08/2017
2	C-Reactive ProteinIBA 07/2018 - 02/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2017 - 12/2007
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2015 - 08/2014
2	Endothelin A ReceptorIBA 08/2013 - 04/2011
2	Carboplatin (JM8)FDA LinkGeneric 10/2012 - 02/2010
1	Albumin-Bound Paclitaxel FDA Link 12/2023
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	Liposomes (Liposome)IBA 11/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	camrelizumabIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	angiogeninIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2020
1	CarbohydratesIBA 07/2020
1	HLA-DR Antigens (HLA-DR)IBA 07/2020
1	Therapeutic UsesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 11/2019
1	InterferonsIBA 11/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2019
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	nimotuzumabIBA 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	AnticoagulantsIBA 12/2018
1	Taxoids (Taxanes)IBA 12/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2018

Therapy/Procedure

46	Radiotherapy 11/2023 - 04/2004
37	Chemoradiotherapy 12/2023 - 10/2009
31	Drug Therapy (Chemotherapy) 11/2023 - 02/2010
23	Induction Chemotherapy 12/2023 - 10/2009
16	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023 - 01/2013
15	Therapeutics 11/2023 - 12/2011
6	Neoadjuvant Therapy 01/2019 - 02/2010
5	Immunotherapy 01/2023 - 02/2015
3	Neck Dissection (Radical Neck Dissection) 11/2022 - 01/2018
3	Re-Irradiation 01/2020 - 07/2007
3	Aftercare (After-Treatment) 10/2019 - 05/2007
3	Catheters 12/2018 - 05/2007
2	Adjuvant Chemotherapy 12/2021 - 01/2019
2	Salvage Therapy 01/2020 - 10/2012
1	TP protocol 01/2022
1	Maintenance Chemotherapy 11/2021